Cardurion Pharmaceuticals, Inc.
New Form D on file · 2022-12-30 · the record
What the record says
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 716 filings in Biotechnology, totalled by week.
Company officers on record
Peter Lawrence is named as Executive Officer and Director on the Form D that Cardurion Pharmaceuticals, Inc. filed with the SEC on 30 December 2022, one of 8 people that filing names.
Michael Mendelsohn is named as Executive Officer and Director on the Form D that Cardurion Pharmaceuticals, Inc. filed with the SEC on 30 December 2022, one of 8 people that filing names.
Kenneth Novack is named as Director on the Form D that Cardurion Pharmaceuticals, Inc. filed with the SEC on 30 December 2022, one of 8 people that filing names.
Jeb Keiper is named as Director on the Form D that Cardurion Pharmaceuticals, Inc. filed with the SEC on 30 December 2022, one of 8 people that filing names.
Amy Schulman is named as Director on the Form D that Cardurion Pharmaceuticals, Inc. filed with the SEC on 30 December 2022, one of 8 people that filing names.
Nicholas Downing is named as Director on the Form D that Cardurion Pharmaceuticals, Inc. filed with the SEC on 30 December 2022, one of 8 people that filing names.
Keith Gottesdiener is named as Director on the Form D that Cardurion Pharmaceuticals, Inc. filed with the SEC on 30 December 2022, one of 8 people that filing names.
Adam Koppel is named as Director on the Form D that Cardurion Pharmaceuticals, Inc. filed with the SEC on 30 December 2022, one of 8 people that filing names.
8 people named on the filing — 2 holding an executive role and 6 as directors only.
Named as of the 2022-12-30 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
- 8 people named on the filing — 2 holding an executive role and 6 as directors only.
No investor is drawn from a Form D — the form states how many invested and never who.
The full profile
Source Check, INVEST, RECRUIT and Press Requests on Cardurion Pharmaceuticals, Inc.
- Source Check — verify Peter Lawrence's other claims against the registers that hold them.
- INVEST — size up this raise on the figures the filing states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Peter Lawrence for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Cardurion Pharmaceuticals, Inc.You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Cardurion Pharmaceuticals, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. FoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.